Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 31, 2024

SELL
$2.93 - $7.32 $73,250 - $183,000
-25,000 Reduced 25.19%
74,251 $543,000
Q3 2023

Oct 31, 2023

SELL
$3.75 - $7.46 $112,500 - $223,800
-30,000 Reduced 23.21%
99,251 $385,000
Q2 2022

Aug 03, 2022

SELL
$1.81 - $8.93 $1.05 Million - $5.18 Million
-579,725 Reduced 81.77%
129,251 $248,000
Q4 2021

Feb 01, 2022

SELL
$9.1 - $13.36 $175,266 - $257,313
-19,260 Reduced 2.64%
708,976 $6.49 Million
Q2 2021

Jul 30, 2021

BUY
$9.77 - $15.33 $82,068 - $128,772
8,400 Added 1.17%
728,236 $8.23 Million
Q1 2021

Apr 30, 2021

BUY
$10.51 - $17.46 $570,955 - $948,514
54,325 Added 8.16%
719,836 $10.9 Million
Q4 2020

Jan 29, 2021

SELL
$7.41 - $12.63 $52,899 - $90,165
-7,139 Reduced 1.06%
665,511 $7.66 Million
Q3 2020

Oct 30, 2020

BUY
$6.16 - $10.3 $1.13 Million - $1.88 Million
182,956 Added 37.36%
672,650 $5.21 Million
Q2 2020

Aug 03, 2020

BUY
$9.02 - $15.12 $175,168 - $293,630
19,420 Added 4.13%
489,694 $5.39 Million
Q1 2020

Apr 30, 2020

BUY
$7.14 - $16.86 $183,805 - $434,026
25,743 Added 5.79%
470,274 $5.14 Million
Q4 2019

Jan 31, 2020

SELL
$13.08 - $17.43 $353,513 - $471,080
-27,027 Reduced 5.73%
444,531 $7.06 Million
Q3 2019

Nov 04, 2019

SELL
$8.65 - $14.81 $98,091 - $167,945
-11,340 Reduced 2.35%
471,558 $6.96 Million
Q2 2019

Jul 31, 2019

BUY
$7.1 - $11.62 $252,454 - $413,172
35,557 Added 7.95%
482,898 $5.61 Million
Q1 2019

May 01, 2019

BUY
$7.95 - $14.07 $953,371 - $1.69 Million
119,921 Added 36.63%
447,341 $4.84 Million
Q4 2018

Jan 31, 2019

BUY
$6.75 - $16.12 $757,856 - $1.81 Million
112,275 Added 52.19%
327,420 $2.67 Million
Q3 2018

Nov 13, 2018

BUY
$13.94 - $19.88 $946,665 - $1.35 Million
67,910 Added 46.12%
215,145 $3.5 Million
Q2 2018

Aug 02, 2018

BUY
$17.5 - $20.34 $2.58 Million - $2.99 Million
147,235 New
147,235 $2.91 Million

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Kornitzer Capital Management Inc Portfolio

Follow Kornitzer Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.